Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: A prospective with quality control 10-year follow-up study

British Journal of Cancer

Volumn 84, Issue 12, 2001, Pages 1602-1609

  Roukos, D H ^a,b   Lorenz, M ^a   Karakostas, K ^b   Paraschou, P ^c   Batsis, C ^b   Kappas, A M ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Extensive surgery; Gastric cancer; Prognostic factors; Recurrence; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; SEROSA; STOMACH CANCER; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 0035875272     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1720     Document Type: Article

References (26)

1. Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer
2. Extended lymph-node dissection for gastric cancer
3. Cytoceratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
4. Lymph-node dissection for gastric cancer
5. Surgical/pathologic-stage migration confounds comparison of gastric cancer survival rates between Japan and Western countries
6. Regression models and life tables
7. Patient survival after D1 and D2 resection for gastric cancer: Long-term results of the MRC randomised surgical trial
8. Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials
9. State of the art in the treatment of gastric cancer: From the 71st Japanese Gastric Cancer Congress
10. Nonparametric estimation from incomplete observations
11. Surgical results with immunochemotherapy
12. Postoperative outcomes of sites of recurrence in patients following curative resection of gastric cancer
13. Progress in gastric cancer surgery in Japan and its limits of radicality
14. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: A randomized trial
15. Japanese classification of gastric carcinoma
16. Current status and future perspectives in gastric cancer management
17. Extended (D2) lymph node dissection for gastric cancer: Do patients benefit?
18. A critical evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomach
19. Evidence of survival benefit of extended lymphadenectomy in Western gastric cancer patients based on a new concept. A prospective long-term follow-up study
20. Distal gastric cancer and extensive surgery: A new evaluation method based on the study of the status of residual lymph nodes after limited surgery
21. Evidence based medicine: What it is and what it isn't
22. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric cancer Study
23. Overoptimisims about cancer
24. Cancer of the stomach: A patient care study by the American College of Surgeons
25. RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview